Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

cardiac amyloidosis on bone scan

Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

Deepak L. Bhatt, MD, discusses research and drug therapies in development to treat lipoprotein (a). #Lp(a)

New drug therapies targeting Lp(a) could be a breakthrough in cardiovascular care

Lipoprotein (a) research is on the rise in recent years. Deepak Bhatt, MD, director of Mount Sinai Fuster Heart Hospital, explains why this trend is so important.

FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary

These safety issues have been linked to more than 800 injuries and two deaths. It is possible, the FDA warned, that some patients may require a device to be removed and replaced. 

A baby in New York underwent open heart surgery as it was being delivered in what is believed to be the first operation of its kind.

Surgeons first in world to perform open heart surgery on baby mid-delivery

The baby had been diagnosed with an especially challenging case of hypoplastic left heart syndrome.

Thumbnail

Ultrasound 'microjets' enable targeted treatment of neurological conditions

It can be difficult to deliver targeted therapy to the brain due to its protective barrier, which only allows certain nutrients and oxygen to pass through.

FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic

The years-long shortage of Wegovy and Ozempic, two popular prescription-only semaglutide injections, is officially over. 

heart data research doctor cardiologist AI

American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

approval regulations checkmark doctor

Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.